APA (7th ed.) Citation

Lee, W., Samyshkin, Y., Langer, J., & Palmer, J. (2012). PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: A Core Diabetes Model Study. Value in Health, A179. https://doi.org/10.1016/j.jval.2012.03.971

Chicago Style (17th ed.) Citation

Lee, W.C, Y. Samyshkin, J. Langer, and J.L Palmer. "PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: A Core Diabetes Model Study." Value in Health 2012: A179. https://doi.org/10.1016/j.jval.2012.03.971.

MLA (9th ed.) Citation

Lee, W.C, et al. "PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: A Core Diabetes Model Study." Value in Health, 2012, p. A179, https://doi.org/10.1016/j.jval.2012.03.971.